“We need to improve our ability to measure protein variants in real time and understand how to correlate to biological significance,” commented Duncan Low, PhD, scientific executive director at Amgen, in a January 28 presentation at the IFPAC 2008 meeting in Baltimore, Maryland. Low’s talk was part of a special...

Link to Article

BioPharm International -- Advanstar Communications Inc.